Neurana Pharmaceuticals

Neurana Pharmaceuticals is a private clinical-stage specialty pharmaceutical company headquartered in San Diego, dedicated to developing new therapies for the treatment of acute muscle spasms. Established in 2013, the company focuses on diseases and conditions of the central nervous system (CNS).Neurana's first drug candidate is tolperisone, which has been proven to be an effective treatment for muscle spasms and spasticity and has been commercialized in markets outside the United States. Clinical studies and commercial use have shown that tolperisone is safe and effective, with non-sedative properties and no potential for addiction.